Join the fight to achieve global malaria elimination targets
Donate today and join the fight to achieve global malaria elimination targets.
Together we can make a significant contribution to achieving malaria elimination targets.
Donate today and join the fight to achieve global malaria elimination targets.
Together we can make a significant contribution to achieving malaria elimination targets.
Our overall aim is to characterise new drug scaffolds and their novel binding sites on HIV reverse transcriptase to advance fundamental understanding of reverse transcriptase structure and function and to underpin the discovery of a new HIV drug class.
This new drug class is aimed to have a distinct mechanism of action and resistance profile to drugs currently used for HIV treatment and prevention
2017 – 2019
Associate Professor David Chalmers Professor Nicolas Sluis-Cremer Professor Eddy Arnold Associate Professor Philip Thompson Dr Stephen Headey Dr Catherine Latham Dr Joseph Bauman Professor Martin Scanlon Professor Susan Charman
NHMRC
For any general enquiries relating to this project, please contact:
Head of Life Sciences; Head of Tachedjian Laboratory (Retroviral Biology and Antivirals)